Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pear Therapeutics, Inc.

Pear Therapeutics, Inc. (PEAR) Stock Overview

Explore Pear Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PEAR●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.03
$0.00(0.00%)
U.S. Market opens in 63h 26m

Pear Therapeutics, Inc. (PEAR)

Meyka AI Score

Z

Key Financials

Market Cap4.1M
P/E Ratio-0.17
EPS (TTM)$-0.36
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PEAR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pear Therapeutics, Inc. (NASDAQ: PEAR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Pear Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PEAR on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Pear Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.17 and a market capitalization of 4.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PEAR on the NASDAQ.

Price Performance (NASDAQ: PEAR)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-97.27%
6-Month Change
-98.45%
Year-to-Date (YTD) Change
-97.48%
1-Year Change
-99.23%
3-Year Change
-99.70%
5-Year Change
-99.70%
All-Time (Max) Change
-99.70%

Contact Information

https://peartherapeutics.com
617 925 7848
200 State Street, Boston, MA, 02109

Company Facts

2,000 Employees
IPO DateMar 31, 2021
CountryUS

Frequently Asked Questions